India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....
More »SEARCH RESULT
Patients rally against trade pact with EU
Patients battling cancer, infections and mental illness joined a rally here today beseeching the government to reject a trade pact with the European Union that they fear will threaten the availability of inexpensive generic medicines in India. An estimated 2,000 people, many among them infected with HIV, walked along Delhi’s Parliament Street on a day when Indian and EU officials were negotiating a free trade agreement in Brussels. Health activists and lawyers...
More »Bhopal gas victims guinea pigs for drug trials by Hemender Sharma
Bhopal gas victims allege that they are being used as guinea pigs for unethical drug trials without being informed.An RTI has revealed that Bhopal Memorial Hospital has pocketed over Rs 1 crore by allowing pharma companies to conduct clinical trials on disaster victims.Shankar Lal was 33 when the Bhopal Union Carbide leak of 1984 happened. Lal and his pregnant wife Laxmi survived but not their child who died at birth....
More »Bhopal gas victims now turn guinea pigs by Subodh Varma
The Bhopal Memorial Hospital and Research Centre (BMHRC) has pocketed over Rs 1 crore by allowing pharma companies to conduct clinical trials of drugs on its patients — victims of the gas disaster of 1984. Shockingly, out of the 7 trials carried out in the hospital since 2004, only one was inspected or monitored by the government watchdog Drug Controller General of India (DCGI). This was revealed in response to...
More »India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India–EU Free Trade Agreement (FTA) negotiations. For instance, EU negotiators have sought India’s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate...
More »